NewsBenzingaGSK FY2031 Revenue expected to be more than $53.204B vs $45.150B Est GSK FY2031 Revenue expected to be more than $53.204B vs $45.150B Est Benzinga 2026.10.28 08:00 (GMT+0) Open on Benzinga Other news Dell Max Pain Points to a Price of $480 by November 20th Dorman Products: Despite Short-Term Issues, The Company Can Drive Higher (NASDAQ:DORM) Extra Space Storage Stock: Better Results, Still Not A Buy (NYSE:EXR) Bitcoin Traders Are Preparing for the Fed in 2 Very Different Ways Allspring Emerging Growth Fund: Q3 2026 Top Contributors And Detractors Diamond Hill Small Cap Fund Q3 2026 Portfolio Activity
